What coagulation factor is affected in a newborn patient with delayed separation of the umbilical cord and bleeding, normal Prothrombin Time (PT), Partial Thromboplastin Time (PTT), platelet count, and function, but delayed clotting time?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Factor XIII Deficiency

The answer is C - Factor XIII deficiency. This clinical presentation of delayed umbilical cord separation with bleeding, normal PT, PTT, platelet count and function, but prolonged clot time is pathognomonic for Factor XIII deficiency 1, 2.

Why Factor XIII Deficiency is the Correct Answer

Factor XIII is the only coagulation factor that stabilizes fibrin clots after they form, and its deficiency is uniquely detected by prolonged clot time rather than PT or PTT 1. Here's the diagnostic reasoning:

  • Normal PT and PTT exclude deficiencies in the intrinsic, extrinsic, and common pathways (Factors II, V, VII, VIII, IX, X, XI, XII), as these would prolong PT and/or PTT 1, 2
  • Normal platelet count and function exclude thrombocytopenia (option D) and platelet disorders 3, 2
  • Factor XIII acts after thrombin converts fibrinogen to fibrin, cross-linking fibrin strands to create a stable clot 1
  • Standard coagulation tests (PT/PTT) measure clot formation up to fibrin generation but do not assess clot stability, which requires Factor XIII 1

Classic Clinical Presentation

Delayed umbilical cord separation (beyond 2-3 weeks) with bleeding is a hallmark presentation of Factor XIII deficiency 4, 5:

  • The umbilical stump requires stable fibrin clot formation for proper separation and hemostasis 4
  • Without Factor XIII, clots form initially (normal PT/PTT) but then break down, causing delayed separation and bleeding 5
  • This presentation has been documented in multiple case series of severe Factor XIII deficiency 4, 5

Why Other Options Are Incorrect

Factor VIII Deficiency (Option A - Hemophilia A)

  • Would prolong PTT, not leave it normal 3
  • Factor VIII is part of the intrinsic pathway, and its deficiency causes prolonged PTT with normal PT 3
  • The normal PTT in this case excludes Factor VIII deficiency 3

Von Willebrand Disease (Option B)

  • Would cause prolonged bleeding time and potentially prolonged PTT, but not isolated prolonged clot time 3
  • Von Willebrand factor affects platelet adhesion (primary hemostasis) and carries Factor VIII 3
  • Normal platelet function in this case excludes von Willebrand disease 3
  • Does not typically cause severe umbilical stump bleeding in newborns 3

Thrombocytopenia (Option D)

  • Explicitly excluded by normal platelet count 3, 2
  • Would not cause isolated prolonged clot time with normal PT/PTT 2

Important Clinical Pitfall

Do not confuse delayed umbilical cord separation as a normal variant 4, 5:

  • Normal cord separation occurs at 7-10 days in term infants 6
  • Separation beyond 3 weeks with bleeding should raise suspicion for Factor XIII deficiency or leukocyte adhesion defects 4, 5
  • While delayed separation can occur with prematurity, sepsis, or antibiotic use, bleeding from the site with normal routine coagulation studies is specific for Factor XIII deficiency 6, 7

Diagnostic Confirmation

The diagnosis is confirmed by specific Factor XIII activity assay 1:

  • Clot solubility test in 5M urea or 1% monochloroacetic acid shows rapid clot dissolution in Factor XIII deficiency 1
  • Factor XIII activity level <1% indicates severe deficiency 1

References

Guideline

Vitamin K Deficiency Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vitamin K Deficiency Bleeding in Newborns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hemophilia B Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The time of separation of the umbilical cord.

European journal of pediatrics, 1987

Related Questions

What is the most likely diagnosis for a baby with delayed separation of the umbilical cord and bleeding from the site, with normal coagulation labs including Prothrombin Time (PT), Partial Thromboplastin Time (PTT), platelet count, and function, but a delay in bleeding time?
What is the likely diagnosis for a baby with delayed separation of the umbilical cord and bleeding from the site, with normal coagulation labs, including normal Prothrombin Time (PT), Partial Thromboplastin Time (PTT), and platelet count and function, but a delay in bleeding time?
What is the most likely diagnosis for a newborn with delayed separation of the umbilical cord, bleeding from the site, prolonged Prothrombin Time (PT) and Partial Thromboplastin Time (PTT), and a normal platelet count?
What is the management for a 26-day-old infant with an intact umbilical cord and no signs of infection?
What is the most likely cause of a newborn's bleeding from the umbilical stump, delayed separation of the umbilical cord, and coagulation study results showing prolonged Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) with a normal platelet count?
What are the techniques, indications, uses, disadvantages, and role in Intensive Care Unit (ICU) of Transcranial Doppler (TCD), and how are its parameters interpreted?
What is the treatment for a woman of reproductive age diagnosed with Gardnerella vaginalis infection?
What is the management approach for a patient with a 5mm echogenic focus of the kidney?
What is the dosage and administration of liquid Bactrim (sulfamethoxazole and trimethoprim) for a patient with impaired renal function?
What is the target non-fasting blood sugar level for a diabetic patient?
What is the treatment approach for a patient with Neuromyelitis Optica Spectrum Disorder (NMOSD) who is also positive for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) using rituximab (rituximab)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.